Literature DB >> 2952681

Visual loss in cryptococcal meningitis.

S Ofner, R S Baker.   

Abstract

Optic neuropathy with visual loss is a well-known complication of chronic elevated intracranial pressure. The association of visual loss with cryptococcal meningitis may reflect the intracranial hypertension often seen in this condition. However, the generally poor results of optic nerve sheath fenestration and analysis of autopsy cases have led to the suggestion that direct invasion of the visual system by organisms may be the more common mechanism of visual loss. We describe a patient with severe visual loss from cryptococcal meningitis in whom organisms were demonstrated in the optic nerve sheath obtained at the time of fenestration. This is the first report to demonstrate this finding in a living patient.

Entities:  

Mesh:

Year:  1987        PMID: 2952681

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  5 in total

1.  Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.

Authors:  Zvi A Kresch; Diego Espinosa-Heidmann; Tiffany Harper; G Jamie Miller
Journal:  Int Ophthalmol       Date:  2012-03-23       Impact factor: 2.031

2.  Anterior visual system involvement in non-Hodgkin's lymphoma.

Authors:  A G Zaman; E M Graham; M D Sanders
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

3.  Presumed multifocal cryptococcol choroidopathy prior to specific systemic manifestation.

Authors:  K Rostomian; P U Dugel; A Kolahdouz-Isfahani; A B Thach; R E Smith; N A Rao
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

4.  Optic nerve sheath fenestration in cryptococcal meningitis.

Authors:  Tatyana Milman; Neena Mirani; Roger E Turbin
Journal:  Clin Ophthalmol       Date:  2008-09

5.  Visual loss in HIV-associated cryptococcal meningitis: A case series and review of the mechanisms involved.

Authors:  Anand Moodley; William Rae; Ahmed Bhigjee
Journal:  South Afr J HIV Med       Date:  2015-10-16       Impact factor: 2.744

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.